Concepedia

Publication | Open Access

Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial

DOIFull Paper Access

24

Citations

20

References

2024

Year

Suzana Margareth Lobo, Gaëtan Plantefève, Girish B. Nair, Adilson Joaquim Westheimer Cavalcante, Nara Franzin de Moraes, Estêvão Portela Nunes, Otis Barnum, Claudio Stadnik, Maria Patelli Juliani Souza Lima, Muriel Lins,
EClinicalMedicine

References

YearCitations

Page 1